128 related articles for article (PubMed ID: 3550623)
1. [In vitro action of fosfomycin combined with rifampicin, pefloxacin and imipenem on staphylococci (checkerboard method in a liquid medium)].
Quentin C; Noury P; Laurent C; Saivin S; Bebear C
Pathol Biol (Paris); 1987 Feb; 35(2):153-7. PubMed ID: 3550623
[TBL] [Abstract][Full Text] [Related]
2. In vitro activity of fosfomycin combined with rifampin, pefloxacin and imipenem against staphylococci: a study by the time-kill curve method.
Quentin C; Saivin S; Lafferriere C; Noury P; Bebear C
Drugs Exp Clin Res; 1987; 13(4):219-24. PubMed ID: 3476291
[TBL] [Abstract][Full Text] [Related]
3. In vitro susceptibility of methicillin-resistant Staphylococcus aureus to imipenem and other antimicrobial agents.
Ishag AJ; Durgham SM; Shibl AM
Chemioterapia; 1987 Aug; 6(4):261-3. PubMed ID: 3477333
[TBL] [Abstract][Full Text] [Related]
4. [In vitro study of the cefamandole-fosfomycin combination against methicillin-resistant staphylococci].
Fosse T; David MF; Duluc F; Darmusey D; Tamalet C; Toga B
Pathol Biol (Paris); 1984 Jun; 32(5 Pt 2):528-31. PubMed ID: 6462742
[TBL] [Abstract][Full Text] [Related]
5. [In vitro study of the effects of an imipenem-fosfomycin combination against clinical strains of Staphylococcus].
Fosse T; David MF; Duluc F
Pathol Biol (Paris); 1986 Dec; 34(10):1055-9. PubMed ID: 3547260
[TBL] [Abstract][Full Text] [Related]
6. [Synergy, addition, indifference, antagonism and dominance. Dominance and antibiotic combination].
Drugeon HB; Dellamonica P; Caillon J
Pathol Biol (Paris); 1987 May; 35(5):495-500. PubMed ID: 3302851
[TBL] [Abstract][Full Text] [Related]
7. In vitro activity of fosfomycin-gentamicin, fosfomycin-ceftazidime, fosfomycin-imipenem and ceftazidime-gentamicin combinations against ceftazidime-resistant Pseudomonas aeruginosa.
Pruekprasert P; Tunyapanit W
Southeast Asian J Trop Med Public Health; 2005 Sep; 36(5):1239-42. PubMed ID: 16438151
[TBL] [Abstract][Full Text] [Related]
8. In vitro interactions between teicoplanin and other antibiotics against enterococci and staphylococci.
Debbia E; Pesce A; Schito GC
J Hosp Infect; 1986 Mar; 7 Suppl A():73-7. PubMed ID: 2871100
[TBL] [Abstract][Full Text] [Related]
9. [Comparative bactericidal kinetics of ciprofloxacin, ofloxacin and pefloxacin alone and in combination against strains of group D Streptococcus].
Zuccarelli M; Simeon de Buochberg M; Maillols M; Armynot du Chatelet AM; Attisso MA
Pathol Biol (Paris); 1988 May; 36(5):403-9. PubMed ID: 3136422
[TBL] [Abstract][Full Text] [Related]
10. In vitro activity of imipenem against enterococci and staphylococci and evidence for high rates of synergism with teicoplanin, fosfomycin, and rifampin.
Debbia E; Varaldo PE; Schito GC
Antimicrob Agents Chemother; 1986 Nov; 30(5):813-5. PubMed ID: 2948444
[TBL] [Abstract][Full Text] [Related]
11. Synergy of fosfomycin with beta-lactam antibiotics against staphylococci and aerobic gram-negative bacilli.
Chin NX; Neu NM; Neu HC
Drugs Exp Clin Res; 1986; 12(12):943-7. PubMed ID: 3569007
[TBL] [Abstract][Full Text] [Related]
12. In vitro activity of linezolid in combination with doxycycline, fosfomycin, levofloxacin, rifampicin and vancomycin against methicillin-susceptible Staphylococcus aureus.
Sahuquillo Arce JM; Colombo Gainza E; Gil Brusola A; Ortiz Estévez R; Cantón E; Gobernado M
Rev Esp Quimioter; 2006 Sep; 19(3):252-7. PubMed ID: 17099793
[TBL] [Abstract][Full Text] [Related]
13. In vitro antibacterial activity of imipenem against Pseudomonas and Staphylococcus species. Comparison with thirteen other antimicrobial agents.
Cristiano P; Abbate GF; Alagia I; Leonessa V; Giaquinto E; Savioli L
Drugs Exp Clin Res; 1985; 11(1):39-48. PubMed ID: 3869802
[TBL] [Abstract][Full Text] [Related]
14. In vitro activity of fosfomycin against 'problem' gram-positive cocci.
Hamilton-Miller JM
Microbios; 1992; 71(287):95-103. PubMed ID: 1453987
[TBL] [Abstract][Full Text] [Related]
15. [In vitro effect of combinations of netilmicin and amikacin with fosfomycin and pefloxacin on 31 strains of heterogeneous methicillin- resistant Staphylococcus aureus].
David C; Chaste A; Saison C; Combremont AG
Pathol Biol (Paris); 1988 Jun; 36(5 Pt 2):608-12. PubMed ID: 3054735
[TBL] [Abstract][Full Text] [Related]
16. [Combination between fosfomycin and oxacillin or cefotaxime against methicillin-resistant Staphylococci and Enterococci].
Duez JM; Kohli E; Pechinot A; Tremeaux JC; Kazmierczak A
Pathol Biol (Paris); 1983 Jun; 31(6):515-8. PubMed ID: 6308543
[TBL] [Abstract][Full Text] [Related]
17. [Fosfomycin resistance in Staphylococcus saprophyticus and other species of coagulase-negative staphylococci].
Loulergue J; Pinon G; Laudat P; Audurier A
Ann Microbiol (Paris); 1984; 135A(2):239-47. PubMed ID: 6721325
[TBL] [Abstract][Full Text] [Related]
18. [In vitro study of the pefloxacine-ceftriaxone combination against 18 strains of Acinetobacter].
Berardi-Grassias L; Bigel ML; Macheboeuf F; Boisivon A; Chauvière P; Guiomar C
Pathol Biol (Paris); 1986 May; 34(5):436-9. PubMed ID: 3534716
[TBL] [Abstract][Full Text] [Related]
19. In vitro antistaphylococcal activity of pefloxacin alone and in combination with other antistaphylococcal drugs.
Fass RJ; Helsel VL
Antimicrob Agents Chemother; 1987 Oct; 31(10):1457-60. PubMed ID: 3481244
[TBL] [Abstract][Full Text] [Related]
20. In vitro activity of minocycline combined with fosfomycin against clinical isolates of methicillin-resistant Staphylococcus aureus.
Sun C; Falagas ME; Wang R; Karageorgopoulos DE; Yu X; Liu Y; Cai Y; Liang B; Song X; Liu Z
J Antibiot (Tokyo); 2011 Aug; 64(8):559-62. PubMed ID: 21772306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
